Guardant Health, Inc. - Common Stock (GH)

Q3 2023 13F Holders as of 9/30/2023

Type / Class
Equity / Common Stock
Shares outstanding
124M
Number of holders
284
Total 13F shares, excl. options
105M
Shares change
-2.41M
Total reported value, excl. options
$3.11B
Value change
-$95.1M
Put/Call ratio
0.46
Number of buys
138
Number of sells
-133
Price
$29.64

Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q3 2023

356 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q3 2023.
Guardant Health, Inc. - Common Stock (GH) has 284 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 105M shares of 124M outstanding shares and own 84.62% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (11M shares), BlackRock Inc. (10M shares), FMR LLC (8.53M shares), Deep Track Capital, LP (4.05M shares), ALLIANCEBERNSTEIN L.P. (3.88M shares), Temasek Holdings (Private) Ltd (3.67M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.59M shares), Capital International Investors (2.93M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.75M shares), and MILLENNIUM MANAGEMENT LLC (2.72M shares).
This table shows the top 284 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.